CC-3, an IgG-based B7-H3xCD3 bispecific antibody for targeting of gastrointestinal cancers

被引：0
|
作者：
Zekri, Latifa [1 ]
Lutz, Martina S. [1 ]
Hagelstein, Ilona [1 ]
Manz, Timo [2 ]
Engel, Monika [1 ]
Klimovich, Boris [1 ]
Prakash, Nisha [1 ]
Chashchina, Anna [1 ]
Hoerner, Sebastian [1 ]
Mueller, Stefanie [1 ]
Maerklin, Melanie [1 ]
Pfluegler, Martin [1 ]
Jung, Gundram [1 ]
Salih, Helmut R. [1 ]
机构：
[1] German Canc Res Ctr DKTK, Tubingen, Germany
[2] Eberhard Karls Univ Tuebingen, Tubingen, Germany
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2865
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Development of a MMAE-based antibody-drug conjugate targeting B7-H3 for glioblastoma
    Mao, Yurong
    Wei, Ding
    Fu, Fengqing
    Wang, Huihui
    Sun, Ziyu
    Huang, Ziyi
    Wang, Yan
    Zhang, Guangbo
    Zhang, Xueguang
    Jiang, Biao
    Chen, Hongli
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 257
  • [22] Tumor-targeting and efficacy of B7H3/GD2 bispecific SNIPER antibodies
    Erbe, Amy K.
    Feils, Arika
    Rosenkrans, Zack
    Wiwczar, Jessica
    Gerhardt, Daniel
    Hammer, Bonnie
    Felder, Mildred
    Bercher, Mark
    Hampton, Alina
    Frankel, Lizzie
    Spiegelman, Dan
    Tsarovsky, Noah
    Rakhmilevich, Alexander
    Hank, Jacquelyn
    Glaser, Bryan
    Hernandez, Reinier
    Green, Roland
    Sondel, Paul M.
    CANCER RESEARCH, 2022, 82 (12)
  • [23] Strengthening of antitumor effects in breast cancer from a novel B7-H4-and CD3-targeting bispecific antibody by an oncolytic virus
    Tang, Jing
    Ma, Xuqian
    Chen, Xin
    Feng, Mingqian
    Jin, Xin
    Wang, Ke
    Wan, Jixi
    Zhu, Xianmin
    Xie, Rong
    Dong, Shuang
    Hu, Sheng
    Jiang, Hui
    Xie, Conghua
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (14)
  • [24] A novel B7-H6/CD3 bispecific IgG-like T cell engaging antibody for the treatment of colorectal cancer.
    Hipp, Susanne
    Zhang, Wei
    Liao, Xiaoyun
    Auguste, Aurelie
    Osswald, Annika
    Bauer, Kathrin
    Walterskirchen, Christian
    Sayedian, Farzaneh H.
    Kellner, Manuela
    Giragossian, Craig
    Voynov, Vladimir
    Nixon, Andrew E.
    Adam, Paul J.
    CANCER RESEARCH, 2021, 81 (13)
  • [25] Development and characterization of NILK-2301, a novel CEACAM5xCD3 κλ bispecific antibody for immunotherapy of CEACAM5-expressing cancers
    Anja Seckinger
    Sara Majocchi
    Valéry Moine
    Lise Nouveau
    Hoang Ngoc
    Bruno Daubeuf
    Ulla Ravn
    Nicolas Pleche
    Sebastien Calloud
    Lucile Broyer
    Laura Cons
    Adeline Lesnier
    Laurence Chatel
    Anne Papaioannou
    Susana Salgado-Pires
    Sebastian Krämer
    Ines Gockel
    Florian Lordick
    Krzysztof Masternak
    Yves Poitevin
    Giovanni Magistrelli
    Pauline Malinge
    Limin Shang
    Sonja Kallendrusch
    Klaus Strein
    Dirk Hose
    Journal of Hematology & Oncology, 16
  • [26] B7-H3 and its role in bone cancers
    He, Lile
    Li, Zhihong
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (06)
  • [27] Development and characterization of NILK-2301, a novel CEACAM5xCD3 κλ bispecific antibody for immunotherapy of CEACAM5-expressing cancers
    Seckinger, Anja
    Majocchi, Sara
    Moine, Valery
    Nouveau, Lise
    Ngoc, Hoang
    Daubeuf, Bruno
    Ravn, Ulla
    Pleche, Nicolas
    Calloud, Sebastien
    Broyer, Lucile
    Cons, Laura
    Lesnier, Adeline
    Chatel, Laurence
    Papaioannou, Anne
    Salgado-Pires, Susana
    Kraemer, Sebastian
    Gockel, Ines
    Lordick, Florian
    Masternak, Krzysztof
    Poitevin, Yves
    Magistrelli, Giovanni
    Malinge, Pauline
    Shang, Limin
    Kallendrusch, Sonja
    Strein, Klaus
    Hose, Dirk
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
  • [28] B7-H3: An Attractive Target for Antibody-based Immunotherapy
    Kontos, Filippos
    Michelakos, Theodoros
    Kurokawa, Tomohiro
    Sadagopan, Ananthan
    Schwab, Joseph H.
    Ferrone, Cristina R.
    Ferrone, Soldano
    CLINICAL CANCER RESEARCH, 2021, 27 (05) : 1227 - 1235
  • [29] COMBINATION OF RHIL-7-HYFC AND ANTI-PD-L1XCD3ε BISPECIFIC ANTIBODY ENHANCES ANTITUMOR RESPONSE IN MICE
    Park, Sujeong
    Kim, Ji-Hae
    Kang, Yeon-Woo
    Lee, Kun-Joo
    Moon, Dain
    Tae, Nara
    Park, Yunji
    Kim, Dae Hee
    Lee, Byung Ha
    Choi, Donghoon
    Yang, Se Hwan
    Lee, Seung-Woo
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A273 - A274
  • [30] Combination therapy with B7H3-redirected bispecific antibody and Sorafenib elicits enhanced synergistic antitumor efficacy
    Huang, Cheng
    Li, Hongjian
    Feng, Yunyu
    Li, Xiaoling
    Zhang, Zongliang
    Jiang, Caiying
    Wang, Jichao
    Yang, Chenli
    Fu, Yuying
    Mu, Min
    Zhao, Shasha
    Wang, Zeng
    Kuang, Yi
    Hou, Huan
    Wang, Yuelong
    Guo, Wenhao
    Xu, Jianguo
    Yang, Hui
    Zhou, Liangxue
    Tong, Aiping
    Guo, Gang
    THERANOSTICS, 2020, 10 (23): : 10498 - 10512
12345